New Therapy Shows Promise For PIK3CA-Related Overgrowth Spectrum in Retrospective Study
source: pixabay.com

New Therapy Shows Promise For PIK3CA-Related Overgrowth Spectrum in Retrospective Study

Data has recently been announced from a study investigating the efficacy of a new therapy called Alpelisib, for the treatment of PIK3CA-related overgrowth spectrum (PROS). The study was called EPIK-P1.…

Continue Reading New Therapy Shows Promise For PIK3CA-Related Overgrowth Spectrum in Retrospective Study

Japan’s Ministry of Health, Labour and Welfare Has Just Announced Their Approval of Alofisel for Crohn’s Disease

Japan's Ministry of Health, Labour, and Welfare has just announced its approval of Alofisel, a stem cell therapy created by Takeda. This approval is specifically for patients who are diagnosed…

Continue Reading Japan’s Ministry of Health, Labour and Welfare Has Just Announced Their Approval of Alofisel for Crohn’s Disease
How to be a Patient Peer: Providing Resources for People with ADPKD
source: shutterstock.com

How to be a Patient Peer: Providing Resources for People with ADPKD

Acknowledgment: This story is sponsored by Otsuka America Pharmaceutical, Inc. and is promoted through the Patient Worthy Collaborative Content program. We only publish content that embodies our mission of providing…

Continue Reading How to be a Patient Peer: Providing Resources for People with ADPKD